Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Winner

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Headache|November 3, 2010
Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study databaseAnthony J Rodgers, Carolyn M Hustad, Roger K Cady, et al.
Headache|February 21, 2022
Patient preference for early onset of efficacy of preventive migraine treatmentsJessica Ailani, Paul Winner, Ann Hartry, et al.
The Lancet. Neurology|May 3, 2017
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trialStewart Tepper, Messoud Ashina, Uwe Reuter, et al.
Mayo Clinic Proceedings|February 9, 2007
Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migrainePaul Winner, Roger K Cady, Gary E Ruoff, et al.
Pediatrics|March 4, 2009
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of ageDonald Lewis, Paul Winner, Joel Saper, et al.
Headache|February 1, 2012
Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized studyIain P Fraser, Lingling Han, Tae H Han, et al.
Cephalalgia : an International Journal of Headache|March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension studyStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Headache|December 6, 2005
Use of the ICHD-II criteria in the diagnosis of pediatric migraineAndrew D Hershey, Paul Winner, Marielle A Kabbouche, et al.
Headache|September 3, 2011
OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical programSheena K Aurora, Paul Winner, Marshall C Freeman, et al.
Headache|September 12, 2008
Obesity in the pediatric headache population: a multicenter studyAndrew D Hershey, Scott W Powers, Timothy D Nelson, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Headache|November 3, 2010
Total migraine freedom, a potential primary endpoint to assess acute treatment in migraine: comparison to the current FDA requirement using the complete rizatriptan study databaseAnthony J Rodgers, Carolyn M Hustad, Roger K Cady, et al.
Headache|February 21, 2022
Patient preference for early onset of efficacy of preventive migraine treatmentsJessica Ailani, Paul Winner, Ann Hartry, et al.
The Lancet. Neurology|May 3, 2017
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trialStewart Tepper, Messoud Ashina, Uwe Reuter, et al.
Mayo Clinic Proceedings|February 9, 2007
Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migrainePaul Winner, Roger K Cady, Gary E Ruoff, et al.
Pediatrics|March 4, 2009
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of ageDonald Lewis, Paul Winner, Joel Saper, et al.
Headache|February 1, 2012
Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized studyIain P Fraser, Lingling Han, Tae H Han, et al.
Cephalalgia : an International Journal of Headache|March 29, 2020
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension studyStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Headache|December 6, 2005
Use of the ICHD-II criteria in the diagnosis of pediatric migraineAndrew D Hershey, Paul Winner, Marielle A Kabbouche, et al.
Headache|September 3, 2011
OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical programSheena K Aurora, Paul Winner, Marshall C Freeman, et al.
Headache|September 12, 2008
Obesity in the pediatric headache population: a multicenter studyAndrew D Hershey, Scott W Powers, Timothy D Nelson, et al.
Pageof 6